Concomitance of numerical chromosomal alterations with structural in an elderly with Alzheimer’s disease: a case report
DOI:
https://doi.org/10.15448/1980-6108.2019.4.34464Keywords:
Autosomal chromosomes, X chromosome, cytogenetics.Abstract
AIMS: To report the first case the concomitance of numerical chromosomal abnormalities with structural as well as chromosomal abnormalities structural in a patient diagnosed with Alzheimer disease in Manaus/Amazonas.
CASE DESCRIPTION: A male patient with 76 years of age was diagnosed with diagnosis of cognitive disorder- Alzheimer’s disease with late onset - temporal variant after laboratory, physical and imaging exams. Cytogenetic analysis was requested for this patient, revealing the presence the concomitant of numerical and structural chromosomal abnormalities with metaphase cells composed of 45 chromosomes with the loss of one of the homologues of chromosome 21 (monosomy) and a deletion of the long arm of one of the homologues of chromosome 1 [45, XY, -21, del (1) (q?)] and metaphase cells containing 46 chromosomes with a deletion of the long arm of one of the homologues of chromosome 15 [(46, XY, del (15) (q?)]. Currently, the patient is in outpatient treatment for maintenance and control of the disease.
CONCLUSIONS: Our study has underlined that karyotyping is one of the fundamental investigations for patients with Alzheimer’s disease. It highlighted, in the form of a chromosomal abnormality, may have been the risk factor in Alzheimer’s disease.
Downloads
References
Morley JE, Farr AS, Nguyen AD. Alzheimer Disease. Clin Geriatr Med. 2018;34(4):591-601. http://dx.doi.org/10.1016/j.cger.2018.06.006
Barranco-Quintana L, Allam F, Del Castillo S, Navajas F. Risk factors for Alzheimer’s disease. Rev Neurol. 2005;40(10):613-18. http://dx.doi.org/10.3389/fnagi.2019.00146
Sochocka M, Zwolińska K, Leszek J. The infectious etiology of alzheimer’s disease. Curr Neuropharmacol. 2017;15(7):996-1009. http://dx.doi.org/10.2174/1570159X15666170313122937
Ashraf GM, Tarasov VV, Makhmutovа A, Chubarev VN, Avila-Rodriguez M, Bachurin SO, Aliev G. The possibility of an infectious etiology of alzheimer disease. Mol Neurobiol. 2019;56(6):4479-91. http://dx.doi.org/10.1007/s12035-018-1388-y
Ahmad MH, Fatima M, Mondal AC. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: rational insights for the therapeutic approaches. J Clin Neurosc. 2018;59:6-11. http://dx.doi.org/10.1016/j.jocn.2018.10.034
Bettens K, Sleegers K, and Broeckhoven CV. Genetic insights in Alzheimer’s disease. Lancet. 2013;12(1):92-104. http://dx.doi.org/10.1016/S1474-4422(12)70259-4
Ward BE, Cook RH, Robinson A, Austin JH. Increased aneuploidy in Alzheimer disease. Am J Med Genet A. 1979;3(2):137-44. http://dx.doi.org/10.1002/ajmg.1320030204
White BJ, Crandall C, Goudsmit J, Morrow CH, Alling DW, Gajdusek DC. Cytogenetic studies of familial and sporadic Alzheimer disease. Am J Med Genet A. 1981;10(1):77-89. http://dx.doi.org/10.1002/ajmg.1320100110
Buckton KE, Whalley LJ, Lee M, Christie JE. Chromosome changes in Alzheimer’s presenile dementia. J Med Genet. 1983;20(1):46-51. http://dx.doi.org/10.1136/jmg.20.1.46
Iourov IY, Vorsanova SG, Liehr T, Yurov YB. Aneuploidy in the normal, Alzheimer’s disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol Dis. 2009;34(2):212-20. http://dx.doi.org/10.1016/j.nbd.2009.01.003
Yurov YB, Vorsanova SG, Liehr T, Kolotii AD, Iourov IY. X chromosome aneuploidy in the Alzheimer’s disease brain. Mol Cytogenet. 2014;7(1):7-20. http://dx.doi.org/10.1186/1755-8166-7-20
Truzzi A, Laks J. Doença de Alzheimer esporádica de início precoce. Rev Psiq Clin. 2005;32(1):43-6. http://dx.doi.org/10.1590/S0101-60832005000100006
Nordensson I, Beckman G, Adolfsson R, Bucht G, Winblad B. Cytogenetic changes in patients with senile dementia. Age Ageing. 1983;12(4):285 95. http://dx.doi.org/10.1093/ageing/12.4.285
Masarweh M. Chromosome 3q29 deletion with gastrointestinal malformation: a case report. J Med Case Rep. 2011;5(5):285-7. http://dx.doi.org/10.1186/1752-1947-5-285
Jhang KM, Chang TM, Chen M, Liu CS. Generalized epilepsy in a patient with mosaic Turner syndrome: a case report. J Med Case Rep. 2014;2(8):109-12. http://dx.doi.org/10.1186/1752-1947-8-109
Smith MAC. Doença de Alzheimer. Rev Bras Psiquiatr. 1999;21(2):1-5. http://dx.doi.org/10.1590/S1516-44461999000600003
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, De Stafano AL, Bis JC, Beecham GW. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45(12):1452-58. http://dx.doi.org/10.1038/ng.2802
Karch CM, Ezerskiy LA, Bertelsen S; Alzheimer’s Disease Genetics Consortium (ADGC) Goate AM. Alzheimer’s disease risk polymorphisms regulate gene expression in the ZCWPW1 and the CELF1 loci. PLoS One. 2016;11(2):e0148717. http://dx.doi.org/10.1371/journal.pone.0148717
Geller LN, Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer’s disease. Neurobiol Dis. 1999;6(3):167-79. http://dx.doi.org/10.1006/nbdi.1999.0236
Bajic VP, Spremo-Potparevic B, Zivkovic L, Bonda DJ, Siedlak SL, Casadesus G, Lee HG, Smith MA. The X-chromosome instability phenotype in Alzheimer’s disease: A clinical sign of accelerating aging? Med Hypotheses. 2009;73(6):917-20. http://dx.doi.org/10.1016/j.mehy.2009.06.046
Bajic V, Mandusic V, Stefanova E, Bozovic A, Davidovic R, Zivkovic L, Cabarkapa A, Spremo-Potparevic B. Skewed X-chromosome inactivation in women affected by Alzheimer’s disease. J Alzheimers Dis. 2015;43(4):1251-59. http://dx.doi.org/10.3233/JAD-141674
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Scientia Medica
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.
